2024
DOI: 10.1016/j.jacl.2024.12.010
|View full text |Cite
|
Sign up to set email alerts
|

Ezetimibe-associated Rhabdomyolysis: A Comprehensive Assessment of the USFDA Adverse Event Reporting System Using Disproportionality Analysis, Case Reviews and Meta-analysis of Randomized Clinical Trials

Kannan Sridharan,
Gowri Sivaramakrishnan
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 34 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?